Neumora Therapeutics, Inc. Common Stock (NMRA) Free Cash Flow
Neumora Therapeutics, Inc. Common Stock (NMRA) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2021-12-31 | -$76.24M |
| 2022-12-31 | -$115.41M |
| 2023-12-31 | -$163.40M |
| 2024-12-31 | -$182.94M |
| 2025-12-31 | -$206.44M |
How NMRA compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| GOSS | Gossamer Bio Inc. | -$171.34M |
| ALEC | Alector Inc. | -$184.07M |
| RCKT | Rocket Pharmaceuticals Inc. | -$190.45M |
| NKTR | Nektar Therapeutics | -$208.68M |
| OCUL | Ocular Therapeutix Inc. | -$216.89M |
These are five companies in the same sector as NMRA with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Neumora Therapeutics, Inc. Common Stock Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("NMRA", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | NMRA | $1.39 | -6.08% | 0.70M |
| 3 | ||||
| 4 | ||||
| 5 |